November 10, 2022 Experience NatWest Group $1.5 billion senior notes offering We advised NatWest Group on the SEC-registered offering
November 10, 2022 Experience Roivant Sciences $150 million equity offering We advised the company on its debut SEC-registered primary and secondary offering
November 3, 2022 Experience Oesterreichische Kontrollbank $1 billion notes offering The notes are due 2025
October 24, 2022 Experience Diageo Capital $2 billion notes offering The investment-grade notes are due 2025, 2027 and 2033
October 19, 2022 Experience British American Tobacco $600 million notes offering The investment-grade notes are due 2032
October 17, 2022 Experience European Biotech Acquisition $200 million combination with Oculis We are advising European Biotech Acquisition Corp. on its deSPAC transaction
September 30, 2022 Experience Gamida Cell $20 million follow-on offering The shares are listed on the Nasdaq Global Select Market
September 27, 2022 Experience EDAP TMS $23 million follow-on offering The ADSs are listed on the Nasdaq Global Market
September 22, 2022 Experience JPMorgan Chase medium-term note program We advised JPMorgan Chase on the euro note program
September 19, 2022 Experience Roivant Sciences $400 million at-the-market offering We advised the company on an SEC-registered at-the-market offering